The role of EGFR-targeting strategies in the treatment of head and neck cancer

@inproceedings{Dequanter2012TheRO,
  title={The role of EGFR-targeting strategies in the treatment of head and neck cancer},
  author={Didier Dequanter and Mohammad Shahla and Pascal Paulus and Philippe H Lothaire},
  booktitle={OncoTargets and therapy},
  year={2012}
}
With its targeted mechanism of action and synergistic activity with current treatment modalities, cetuximab is a potentially valuable treatment option for patients with recurrent and/or metastatic squamous cell cancer of the head and neck who have progressed on cisplatin-based chemotherapy. The use of cetuximab in combination with radiotherapy as definitive treatment for locoregionally advanced squamous cell cancer of the head and neck is generally restricted to patients unfit to receive… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
4 Citations
28 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 28 references

: state of the art 2007 and review of clinical applications

  • J Bernier, D Schneider
  • 2008

Similar Papers

Loading similar papers…